Sodzi Sodzi-Tettey

Also known as: Dr Sodzi Sodzi-Tettey · Dr. Sodzi Sodzi-Tettey · Dr Sodzi-Tettey

CEO of Ghana's National Vaccine Institute, leading vaccine manufacturing development and clinical trial initiatives.

2026-05-202026-10-10

In coverage

Verbatim sentences from the source article.

June 2026
5 JunThe Ghanaian Times
… ana and regions such as Oti demonstrated stronger trust and acceptance of vaccines. “These regional variations underscore the importance of targeted and context-specific communication strategies,” a statement signed by the Chief Executive Officer of the NVI, Dr Sodzi Sodzi-Tettey …
Only 14.3% aware of Ghana’s local vaccine production plan – Survey
May 2026
20 MayJoy Online
… If the health sector seizes the moment, this grand opportunity that the President has offered us, we stand the chance of being the most articulate definition of the Mahama legacy tenure. ******* The writer, Sodzi Sodzi-Tettey, is the CEO of the National Vaccine Institute and can …
Sodzi Sodzi-Tettey: One year of working for John Mahama

Society

NVI CEO defends GH¢13m spending on training and workshops

The News

The National Vaccine Institute's CEO has defended the Institute's GH¢13 million expenditure on training, workshops and conferences in 2025, arguing the spending supports development of Ghana's vaccine manufacturing sector by building capacity among researchers, manufacturers and regulators. The defence comes after the Auditor-General reported the Institute moved from a GH¢36 million profit to a GH¢21 million loss within the financial year.

13 hours ago · Joy Online →

Yesterday

NVI CEO defends GH¢13m spending on training and workshops
The National Vaccine Institute's CEO has defended the Institute's GH¢13 million expenditure on training, workshops and conferences in 2025, arguing the spending supports development of Ghana's vaccine manufacturing sector by building capacity among researchers, manufacturers and regulators. The defence comes after the Auditor-General reported the Institute moved from a GH¢36 million profit to a GH¢21 million loss within the financial year.
13 hours ago · Joy Online →
Ghana to manufacture tetanus-diphtheria vaccine by 2027
Ghana is expected to produce its first locally manufactured vaccine—a tetanus-diphtheria vaccine—by 2027 through Atlantic Lifesciences Limited, with production supported by a partnership involving local institutions, private manufacturers, and an Indonesian pharmaceutical company. The National Vaccine Institute has completed a technology transfer agreement with Indonesia to reduce Ghana's reliance on imported vaccines.
13 hours ago · Joy Online →

Thursday 10 September

Ghana to pre-qualify local vaccine manufacturers for African market
The CEO of Ghana's National Vaccine Institute said the country is preparing to pre-qualify Ghanaian companies to manufacture vaccines for local and wider African markets, following Ghana's decision to join the Africa Pool Procurement Mechanism. A regional meeting is planned for November in Accra to launch an application process for assessing and pre-qualifying eligible companies.
10 September 2026 · Joy Online →

Monday 7 September

Ghana signs agreement to boost vaccine and pharmaceutical manufacturing
Ghana has signed a Memorandum of Understanding on August 21, 2026, to participate in the African Pooled Procurement Mechanism, giving Ghanaian pharmaceutical and vaccine manufacturers access to a larger continental market and creating more predictable demand for locally manufactured health products.
7 September 2026 · Joy Online →
Ghanaian vaccine makers gain continental market access via Africa CDC deal
Ghana has signed a Memorandum of Understanding with the Africa Centres for Disease Control and Prevention to join the African Pooled Procurement Mechanism, granting Ghanaian vaccine and pharmaceutical manufacturers access to a market of about 1.4 billion people across all 55 African Union member states.
7 September 2026 · Joy Online →

Thursday 27 August

Ghana pilots WHO benchmarking tool for clinical trial systems
Ghana has been selected as one of eight countries worldwide to pilot a WHO benchmarking tool designed to assess and strengthen institutional capacity for conducting high-quality clinical trials. The tool examines seven functional areas across 32 objectives and 112 outcomes, and 13 Ghanaian institutions participated in an assessment exercise.
27 August 2026 · Joy Online →

Monday 24 August

Ghana receives €2 million for pharmaceutical research and vaccine innovation
Eight Ghanaian research institutions and pharmaceutical companies have been awarded €2 million in grants under the PharmaVax Ghana programme to develop vaccines, medicines, and health products. The projects, jointly funded by Germany and the EU and implemented by GIZ, cover innovations in malaria treatment, monoclonal antibodies, diagnostics, and herbal remedies for various conditions.
24 August 2026 · Joy Online →

Wednesday 10 June

Ghana's National Vaccine Institute joins WHO Global Clinical Trials Forum
Ghana's National Vaccine Institute has been admitted to the WHO-managed Global Clinical Trials Forum, a network that supports stronger clinical trial systems globally. The membership provides Ghana with technical support and collaboration opportunities at no financial cost.
10 June 2026 · Joy Online →
Ghana's National Vaccine Institute joins WHO Global Clinical Trials Forum
Ghana's National Vaccine Institute has been admitted to the WHO-managed Global Clinical Trials Forum, a network supporting the development of stronger clinical trial systems globally. The membership provides Ghana with technical support and collaboration opportunities at no financial cost to the institute.
10 June 2026 · Joy Online →

Friday 5 June

NVI seeks investors for local vaccine manufacturing by 2030
Ghana's National Vaccine Institute is seeking partnerships with investors including Ghana Exim Bank, Afreximbank, and the International Finance Corporation to fund local vaccine manufacturers, as GAVI funding ends in 2030 and Ghana will need to fund vaccines locally at about $50 million in four years. The NVI has signed a tech transfer agreement with PT Biopharma of Indonesia for tetanus-diphtheria vaccine manufacturing locally by 2027.
5 June 2026 · Joy Online →
14.3% of Ghanaians aware of local vaccine production plan
A nationwide survey by the National Vaccine Institute found that only 14.3 per cent of Ghanaians are aware of plans to begin local vaccine production in 2027, highlighting the need for intensified public education despite high general confidence in vaccines. The survey of 13,905 valid responses across all 16 regions and 55 districts revealed regional disparities, with rural communities in northern Ghana showing stronger vaccine acceptance than urbanised regions like Greater Accra and Ashanti.
5 June 2026 · The Ghanaian Times →

Wednesday 20 May

Sodzi-Tettey reflects on year serving President John Mahama
A government official recounts his first year working under President John Mahama, highlighting the President's grasp of public sector processes and the swift implementation of solutions, and noting that Mahama's Accra Reset Agenda has gained attention in the global health community.
20 May 2026 · Joy Online →